Letter of Support and Financing Commitment from Paseco ApS to Dandrit Biotech A/S (May 2, 2014)

Summary

Paseco ApS, a shareholder of the parent company of Dandrit Biotech A/S, commits to provide up to DKK 2 million in additional financing to Dandrit Biotech A/S to support its operations until February 1, 2015. Dandrit Biotech A/S may request the loan in full or in smaller installments as needed. Any loans provided under this commitment will follow the same terms as existing loans between the parties, as set out in their April 30, 2014 loan agreement.

EX-10.7 3 f10q0314ex10vii_dandritbio.htm LETTER OF SUPPORT OF PASECO APS RELATED TO COMMITTED 2M DKK IN ADDITIONAL FINANCING, DATED MAY 2, 2014. f10q0314ex10vii_dandritbio.htm
Exhibit 10.7
 
LETTER OF SUPPORT
 
The undersigned, Paseco ApS CVR. - No 31 36 36 08, which is a shareholder of the parent company to Dandrit Biotech A/S CVR. - No. 26 02 73 22 hereby issue the following letter of support in the amount of DKK 2m to Dandrit Biotech A/S to ensure continued operation until 1 February 20 15.
 
Dandrit Biotech A/S can call in the loan at their di scretion at either the full amount of DKK 2m or in any smaller installments.
 
Any loan issued under this note will be subject to the same term s as the current loans from Paseco ApS to Dandrit Biotech A/S issued under loan agreement signed on 30 April 2014.

On behalf of Paseco ApS
Copenhagen, 2/5-2014
 
/s/ Ole Abildgaard                                 
Ole Abildgaard